• Prospective evaluation of a gene signature as a new prognostic tool in early stage breast cancer: Background and challenges in the design of MINDACT (Microarray In Node negative Disease May Avoid Chemotherapy Trial)
Auteur:Bogaerts, Jan; Cardoso, Fatima; Buyse, Marc; Braga, Sofia; Loi, Sherene; Harrison, Jillian A; Bines, Jacques; Mook, Stella; Decker, Nuria; Therasse, Patrick; Rutgers, Emiel; Van't Veer, Laura; Piccart-Gebhart, Martine
Informations sur la publication:Nature clinical practice oncology, 3, 10, page (540-551)
Statut de publication:Publié, 2006
Sujet CREF:Cancérologie